Ayala Pharmaceuticals Insiders
ADXSDelisted Stock | USD 0.62 0.03 4.62% |
Breaking down Ayala Pharmaceuticals' management performance can provide insight into the firm performance.
Ayala |
Symbol | ADXS |
Name | Ayala Pharmaceuticals |
Type | OTC Stock |
Country | United States |
Exchange | OTCQX |
Information on Ayala Pharmaceuticals Leadership is currently not available.
If you believe this information is not accurate please let us know and we will check it out. Check all delisted instruments across multiple markets.Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Thematic Opportunities
Explore Investment Opportunities
Ayala Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of (24.13) % which means that it has lost $24.13 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (41.98) %, meaning that it created substantial loss on money invested by shareholders. Ayala Pharmaceuticals' management efficiency ratios could be used to measure how well Ayala Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Ayala Pharmaceuticals Workforce Comparison
Ayala Pharmaceuticals is number one stock in number of employees category among related companies. The total workforce of Biotechnology industry is presently estimated at about 50.0. Ayala Pharmaceuticals totals roughly 14.0 in number of employees claiming about 28% of stocks in Biotechnology industry.
About Ayala Pharmaceuticals Management Performance
The success or failure of an entity such as Ayala Pharmaceuticals often depends on how effective the management is. Ayala Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Ayala management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Ayala management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes technology antigen delivery products in the United States. Advaxis, Inc. was founded in 2002 and is based in Monmouth Junction, New Jersey. Advaxis operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 14 people.
The data published in Ayala Pharmaceuticals' official financial statements usually reflect Ayala Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Ayala Pharmaceuticals. For example, before you start analyzing numbers published by Ayala accountants, it's critical to develop an understanding of what Ayala Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Ayala Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Ayala Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Ayala Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Ayala Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Ayala Pharmaceuticals' management manipulating its earnings.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Ayala OTC Stock
If you are still planning to invest in Ayala Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ayala Pharmaceuticals' history and understand the potential risks before investing.
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Stocks Directory Find actively traded stocks across global markets | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |